UBS Group »

Avenue Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Avenue Therapeutics (ATXI) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Avenue Therapeutics

Jul 2024Aug 2024Sep 2024Oct 2024Nov 2024Dec 2024Jan 20255k10k15k2000400060008000
Value ($)Share countHistorical ATXI position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Avenue Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avenue Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $16k 7.9k 2.00
2024-09-30 $15k 6.1k 2.49
2024-06-30 $2.4k 673 3.50

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Avenue Therapeutics

Ikarian Capital
Boothbay Fund Management
UBS Group
Tower Research Capital
Wells Fargo & Company
Bank of America Corporation
SBI Securities

View all funds holding Avenue Therapeutics